Intrapleural Catheter Daily Versus Three Times a Week Drainage

StatusActive, Not Recruiting
PhasePhase 2
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 years later Aug 31, 2026 → Aug 31, 2028
See other at-risk trials from M.D. Anderson Cancer Center

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Aug 31, 2026 to Aug 31, 2028
    • Eligibility criteria expanded, about 11 words
    • Study description expanded, about 6 words
  2. 3 versions Re-verified since May 19, 2025, no change to tracked fieldsv36-v38
  3. Primary and study completion dates: Aug 31, 2024 to Aug 31, 2026v35
  4. 4 versions Re-verified since Aug 24, 2022, no change to tracked fieldsv31-v34
  5. Primary and study completion dates: Mar 2022 to Aug 31, 2024
    • Enrollment target: estimated 280 to confirmed 257
    • Start date: Mar 2009 to Aug 22, 2008
    v30
Show 28 earlier versionsHide 28 earlier versions
  1. Phase: Phase 3 to Phase 2
    • Primary and study completion dates: Mar 2021 to Mar 2022
    v29
  2. Primary completion date: Mar 2020 to Mar 2021v28
  3. Study completion date: Mar 2020 to Mar 2021v27
  4. Re-verified, no change to tracked fieldsv26
  5. Primary completion date: Aug 2018 to Mar 2020
    • Study completion date: Mar 2020
    v25
  6. Study description revisedv24
  7. Primary completion date: Aug 2017 to Aug 2018v23
  8. Primary completion date: Aug 2016 to Aug 2017v22
  9. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v21
  10. Enrollment target: 250 to 280
    • Study description revised
    • Study site revised
    v20
  11. Study description shortened, about 4 wordsv19
  12. Primary completion date: Aug 2015 to Aug 2016v18
  13. Study description expanded, about 4 wordsv17
  14. Eligibility criteria expanded, about 11 words
    • Collaborators expanded, about 3 words
    v16
  15. Primary endpoint revised
    • Study description shortened, about 13 words
    v15
  16. Re-verified, no change to tracked fieldsv14
  17. Primary completion date: Aug 2014 to Aug 2015v13
  18. Re-verified, no change to tracked fieldsv12
  19. Eligibility criteria expanded, about 9 wordsv11
  20. Study description expanded, about 13 wordsv10
  21. Primary completion date: Aug 2013 to Aug 2014v9
  22. Study description shortened, about 2 wordsv8
  23. Primary completion date: Aug 2012 to Aug 2013v7
  24. Trial status: Active, Not Recruiting to Recruitingv6 Show 4 more changesShow less
    • Primary completion date: Aug 2011 to Aug 2012
    • Enrollment target: 310 to 250
    • Study description revised
    • Site details revised
  25. Primary endpoint revisedv5
  26. 2 versions Re-verified since Feb 17, 2010, no change to tracked fieldsv3-v4
  27. Start date: Aug 2008 to Mar 2009
    • Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    • Eligibility criteria expanded, about 2 words
    v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical research study is to learn if draining the IPC every day is better at than draining it 3 times a week.
Trial Details
NCT Number NCT00761618
Lead Sponsor M.D. Anderson Cancer Center
Collaborators: C. R. Bard
Conditions
(from sponsor)		 Advanced Cancer, Pleural Effusion
Related terms Pleural Effusion, Pleural Effusion, Malignant
Enrollment 257 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov